{
    "2018-03-21": [
        [
            {
                "time": "2018-03-21",
                "original_text": "浙商证券：医药生物大部制改革推进 行业政策暖风吹",
                "features": {
                    "keywords": [
                        "医药生物",
                        "大部制改革",
                        "行业政策",
                        "暖风"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "[推荐评级] 医药生物行业周报：大幅反弹之后 寻找新的估值支撑",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "大幅反弹",
                        "估值支撑"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "【浙商医药】行业点评：行业拐点元年，创新提速，强者恒强",
                "features": {
                    "keywords": [
                        "医药",
                        "行业拐点",
                        "创新提速",
                        "强者恒强"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "浙商早班车2018.03.21",
                "features": {
                    "keywords": [
                        "浙商早班车"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "302股披露最新股东户数 逾六成筹码趋向集中",
                "features": {
                    "keywords": [
                        "股东户数",
                        "筹码集中"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}